Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica ; volume:15 ; number:1 ; day:22 ; month:10 ; year:2018 ; pages:1-11 ; date:12.2018
Journal of neuroinflammation ; 15, Heft 1 (22.10.2018), 1-11, 12.2018
- Urheber
-
Duan, Tianjiao
- Beteiligte Personen und Organisationen
-
Smith, Alex J.
Verkman, Alan S.
SpringerLink (Online service)
- DOI
-
10.1186/s12974-018-1333-z
- URN
-
urn:nbn:de:101:1-2018112523020597688609
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Duan, Tianjiao
- Smith, Alex J.
- Verkman, Alan S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
The history of neuromyelitis optica
Schwannzell-Remyelinisierung bei Neuromyelitis optica
Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
Neuromyelitis optica
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
The history of neuromyelitis optica